Cargando…

Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction

AIMS: Heart failure with preserved ejection fraction (HFpEF) poses a substantial challenge for clinicians, but there is little guidance for effective management. The aim of this systematic review was to determine if there was evidence that disease management programmes (DMPs) improved outcomes for p...

Descripción completa

Detalles Bibliográficos
Autores principales: Kalogirou, Fotini, Forsyth, Faye, Kyriakou, Martha, Mantle, Rhys, Deaton, Christi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083420/
https://www.ncbi.nlm.nih.gov/pubmed/31978280
http://dx.doi.org/10.1002/ehf2.12559
_version_ 1783508530226003968
author Kalogirou, Fotini
Forsyth, Faye
Kyriakou, Martha
Mantle, Rhys
Deaton, Christi
author_facet Kalogirou, Fotini
Forsyth, Faye
Kyriakou, Martha
Mantle, Rhys
Deaton, Christi
author_sort Kalogirou, Fotini
collection PubMed
description AIMS: Heart failure with preserved ejection fraction (HFpEF) poses a substantial challenge for clinicians, but there is little guidance for effective management. The aim of this systematic review was to determine if there was evidence that disease management programmes (DMPs) improved outcomes for patients with HFpEF. METHODS AND RESULTS: A systematic review of controlled studies in English or Greek of DMPs including patients with HFpEF from 2008 to 2018 was conducted using CINAHL, Cochrane, MEDLINE, and Embase. Interventions were assessed using a DMP taxonomy and scored for complexity and intensity. Bias was assessed using the Cochrane Collaboration tool. Initial and updated searches found 6089 titles once duplicates were removed. The final analysis included 18 studies with 5435 HF patients: 1866 patients (34%, study ranges 18–100%) had potential HFpEF (limited by variable definitions). Significant heterogeneity in terms of the population, intervention, comparisons, and outcomes prohibited meta‐analysis. Statistically significant or positive trends were found in mortality, hospitalization rates, self‐care ability, quality of life, anxiety, depression, and sleep, but findings were not robust or consistent. Four studies reported results separately for study‐defined HFpEF, with two finding less positive effect on outcomes. CONCLUSIONS: Varying definitions of HFpEF used in studies are a substantial limitation in interpretation of findings. The reduced efficacy noted in contemporary HF DMP studies may not only be due to improvements in usual care but may also reflect inclusion of heterogeneous patients with HFpEF or HF with mid‐range EF who may not respond in the same way as HFrEF to individual components. Given that patients with HFpEF are older and multi‐morbid, DMPs targeting HFpEF should not rely on a single‐disease focus but provide care that addresses predisposing and presentation phenotypes and draws on the principles of comprehensive geriatric assessment. Other components could also be more targeted to HFpEF such as modification of lifestyle factors for which there is emerging evidence, rather than simply continuing the model of care used in HFrEF. Based on current evidence, HF DMPs may improve mortality, hospitalization rates, self‐care, and quality of life in patients with HFpEF; however, further research specifically tailored to appropriately defined HFpEF is required.
format Online
Article
Text
id pubmed-7083420
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-70834202020-03-24 Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction Kalogirou, Fotini Forsyth, Faye Kyriakou, Martha Mantle, Rhys Deaton, Christi ESC Heart Fail Original Research Articles AIMS: Heart failure with preserved ejection fraction (HFpEF) poses a substantial challenge for clinicians, but there is little guidance for effective management. The aim of this systematic review was to determine if there was evidence that disease management programmes (DMPs) improved outcomes for patients with HFpEF. METHODS AND RESULTS: A systematic review of controlled studies in English or Greek of DMPs including patients with HFpEF from 2008 to 2018 was conducted using CINAHL, Cochrane, MEDLINE, and Embase. Interventions were assessed using a DMP taxonomy and scored for complexity and intensity. Bias was assessed using the Cochrane Collaboration tool. Initial and updated searches found 6089 titles once duplicates were removed. The final analysis included 18 studies with 5435 HF patients: 1866 patients (34%, study ranges 18–100%) had potential HFpEF (limited by variable definitions). Significant heterogeneity in terms of the population, intervention, comparisons, and outcomes prohibited meta‐analysis. Statistically significant or positive trends were found in mortality, hospitalization rates, self‐care ability, quality of life, anxiety, depression, and sleep, but findings were not robust or consistent. Four studies reported results separately for study‐defined HFpEF, with two finding less positive effect on outcomes. CONCLUSIONS: Varying definitions of HFpEF used in studies are a substantial limitation in interpretation of findings. The reduced efficacy noted in contemporary HF DMP studies may not only be due to improvements in usual care but may also reflect inclusion of heterogeneous patients with HFpEF or HF with mid‐range EF who may not respond in the same way as HFrEF to individual components. Given that patients with HFpEF are older and multi‐morbid, DMPs targeting HFpEF should not rely on a single‐disease focus but provide care that addresses predisposing and presentation phenotypes and draws on the principles of comprehensive geriatric assessment. Other components could also be more targeted to HFpEF such as modification of lifestyle factors for which there is emerging evidence, rather than simply continuing the model of care used in HFrEF. Based on current evidence, HF DMPs may improve mortality, hospitalization rates, self‐care, and quality of life in patients with HFpEF; however, further research specifically tailored to appropriately defined HFpEF is required. John Wiley and Sons Inc. 2020-01-24 /pmc/articles/PMC7083420/ /pubmed/31978280 http://dx.doi.org/10.1002/ehf2.12559 Text en © 2020 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of the European Society of Cardiology This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research Articles
Kalogirou, Fotini
Forsyth, Faye
Kyriakou, Martha
Mantle, Rhys
Deaton, Christi
Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
title Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
title_full Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
title_fullStr Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
title_full_unstemmed Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
title_short Heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
title_sort heart failure disease management: a systematic review of effectiveness in heart failure with preserved ejection fraction
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083420/
https://www.ncbi.nlm.nih.gov/pubmed/31978280
http://dx.doi.org/10.1002/ehf2.12559
work_keys_str_mv AT kalogiroufotini heartfailurediseasemanagementasystematicreviewofeffectivenessinheartfailurewithpreservedejectionfraction
AT forsythfaye heartfailurediseasemanagementasystematicreviewofeffectivenessinheartfailurewithpreservedejectionfraction
AT kyriakoumartha heartfailurediseasemanagementasystematicreviewofeffectivenessinheartfailurewithpreservedejectionfraction
AT mantlerhys heartfailurediseasemanagementasystematicreviewofeffectivenessinheartfailurewithpreservedejectionfraction
AT deatonchristi heartfailurediseasemanagementasystematicreviewofeffectivenessinheartfailurewithpreservedejectionfraction